DANVILLE — Dr. Robert J. Weil will join Geisinger Health System as its chief medical executive for the northeast region and the systems’s associate chief scientific officer on Nov. 11.
Previously associated with the Cleveland Clinic, Weil served as president of Lakewood Hospital in Lakewood, Ohio, and was a member of the Cleveland Clinic Board of Governors. Weil also served as chief of neurosurgery at Nashville Veterans Administration Hospital; head of the unit on tumor biology and surgical therapeutics at the National Institute of Neurological Disorders and Stroke in Bethesda; and associate professor in the department of neurosurgery at George Washington University in Washington, DC.
As Geisinger’s physician executive for northeast Pennsylvania, he will lead building programs and services at Geisinger-Community Medical Center, Geisinger Wyoming Valley Medical Center, Geisinger South Wilkes-Barre. Weil will also have a clinical practice in neurological surgery, primarily located at Geisinger Community Medical Center, specializing in brain and pituitary tumors. Additionally, in his role as system associate chief scientific officer, Weil will focus on expanding clinical research throughout Geisinger Health System’s northeast and central Pennsylvania service areas.
“Dr. Weil brings a wealth of administrative, medical and research expertise, and we are pleased to welcome him to the Geisinger family,” said Dr. Glenn Steele, Jr., Geisinger Health System’s president and chief executive officer. “Geisinger and our patients will benefit from his leadership, surgical expertise and research accomplishments.”
Weil earned his Bachelor of Arts degree at Yale University and Medical Degree at the University of Missouri. He also holds a Master of Business Administration from Case Western Reserve University.
Weil completed residencies in general surgery and otolaryngology at the University of Chicago, pathology at Jewish Hospital and Washington University School of Medicine in St. Louis, and neurosurgery at the University of Pennsylvania in Philadelphia. He also completed a post-doctoral research fellowship at the University of Pennsylvania, epilepsy surgery fellowship at Graduate Hospital in Philadelphia, and pituitary surgery and neurosurgical oncology fellowships at the National Institutes of Health in Bethesda, Md.
His research interests include molecular genetics of primary and metastatic brain and pituitary tumors, and the application of novel pathological and molecular techniques to diagnose and treat neurologic and oncologic diseases.